Our study also revealed new cancer types harbouring known fusions (for example, BRAF fusion in rectal adenocarcinoma, FGFR3 fusion in prostate adenocarcinoma, RET fusions in colon adenocarcinoma and invasive breast carcinoma, EGFR–SEPT14 in low-grade glioma, and so on). The gene discussed is FGFR3; the disease is colon adenocarcinoma.